{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:56:02Z","timestamp":1782827762941,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CMRPG3G1191"],"award-info":[{"award-number":["CMRPG3G1191"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CMRPG3J1901-2"],"award-info":[{"award-number":["CMRPG3J1901-2"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Blau syndrome (BS) is a rare autoinflammatory disorder with <jats:italic>NOD2<\/jats:italic> gain-of-function mutation and characterized by autoactivation of the NF\u03baB pathway. Classically considered a disease of high penetrance, reports on <jats:italic>NOD2<\/jats:italic> mutations underlining BS with incomplete penetrance is limited.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>The proband is a 9-year-old girl presented with brownish annular infiltrative plaques and symmetric boggy polyarthritis over bilateral wrists and ankles. Her skin biopsy revealed noncaseating granulomas inflammation with multinucleated giant cells. A novel C483W <jats:italic>NOD2<\/jats:italic> mutation was identify in the proband and her asymptomatic father. Functional examinations including autoactivation of the NF\u03baB pathway demonstrated by <jats:italic>in vitro<\/jats:italic> HEK293T NOD2 overexpression test as well as intracellular staining of phosphorylated-NF\u03baB in patient\u2019s CD11b<jats:sup>+<\/jats:sup> cells were consistent with BS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We reported a novel C483W <jats:italic>NOD2<\/jats:italic> mutation underlining BS with incomplete penetrance. Moreover, a phosphorylated-NF\u03baB intracellular staining assay of CD11b<jats:sup>+<\/jats:sup> was proposed to assist functional evaluation of NF\u03baB autoactivation in patient with BS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-022-00743-1","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T12:02:51Z","timestamp":1664798571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Incomplete penetrance of NOD2 C483W mutation underlining Blau syndrome"],"prefix":"10.1186","volume":"20","author":[{"given":"Shao-Yu","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotomo","family":"Kambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Lang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Long","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-I","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"issue":"1","key":"743_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.autrev.2012.07.028","volume":"12","author":"P Sfriso","year":"2012","unstructured":"Sfriso P, Caso F, Tognon S, Galozzi P, Gava A, Punzi L. Blau syndrome, clinical and genetic aspects. Autoimmun Rev. 2012;12(1):44\u201351.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"743_CR2","doi-asserted-by":"publisher","first-page":"e000097","DOI":"10.1136\/rmdopen-2015-000097","volume":"1","author":"F Caso","year":"2015","unstructured":"Caso F, Galozzi P, Costa L, Sfriso P, Cantarini L, Punzi L. Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn\u2019s disease. RMD Open. 2015;1(1):e000097.","journal-title":"RMD Open"},{"issue":"1","key":"743_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ng720","volume":"29","author":"C Miceli-Richard","year":"2001","unstructured":"Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, Hafner R, et al. CARD15 mutations in Blau syndrome. Nat Genet. 2001;29(1):19\u201320.","journal-title":"Nat Genet"},{"key":"743_CR4","doi-asserted-by":"publisher","first-page":"11813","DOI":"10.1038\/ncomms11813","volume":"7","author":"S Maekawa","year":"2016","unstructured":"Maekawa S, Ohto U, Shibata T, Miyake K, Shimizu T. Crystal structure of NOD2 and its implications in human disease. Nat Commun. 2016;7:11813.","journal-title":"Nat Commun"},{"issue":"2","key":"743_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11882-021-00991-3","volume":"21","author":"KP Kaufman","year":"2021","unstructured":"Kaufman KP, Becker ML. Distinguishing Blau syndrome from systemic sarcoidosis. Curr Allergy Asthma Rep. 2021;21(2):10.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"18","key":"743_CR6","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1016\/j.febslet.2014.07.029","volume":"588","author":"R Parkhouse","year":"2014","unstructured":"Parkhouse R, Boyle JP, Monie TP. Blau syndrome polymorphisms in NOD2 identify nucleotide hydrolysis and helical domain 1 as signalling regulators. FEBS Lett. 2014;588(18):3382\u20139.","journal-title":"FEBS Lett"},{"issue":"6","key":"743_CR7","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1002\/art.24532","volume":"60","author":"FT Saulsbury","year":"2009","unstructured":"Saulsbury FT, Wouters CH, Martin TM, Austin CR, Doyle TM, Goodwin KA, et al. Incomplete penetrance of the NOD2 E383K substitution among members of a pediatric granulomatous arthritis pedigree. Arthritis Rheum. 2009;60(6):1804\u20136.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"743_CR8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.mayocpiqo.2019.04.006","volume":"3","author":"P Ungprasert","year":"2019","unstructured":"Ungprasert P, Ryu JH, Matteson EL. Clinical manifestations, diagnosis, and treatment of sarcoidosis. Mayo Clin Proc Innov Qual Outcomes. 2019;3(3):358\u201375.","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"4","key":"743_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/diagnostics9040160","volume":"9","author":"B Chiu","year":"2019","unstructured":"Chiu B, Chan J, Das S, Alshamma Z, Sergi C. Pediatric sarcoidosis: a review with emphasis on early onset and high-risk sarcoidosis and diagnostic challenges. Diagnostics (Basel). 2019;9(4):160.","journal-title":"Diagnostics (Basel)"},{"issue":"11","key":"743_CR10","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1136\/annrheumdis-2020-217320","volume":"79","author":"T Matsuda","year":"2020","unstructured":"Matsuda T, Kambe N, Ueki Y, Kanazawa N, Izawa K, Honda Y, et al. Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation. Ann Rheum Dis. 2020;79(11):1492\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"743_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/13816810.2021.1946701","volume":"42","author":"FG Rodrigues","year":"2021","unstructured":"Rodrigues FG, Petrushkin H, Webster AR, Bickerstaff M, Moraitis E, Rowczenio D, et al. A novel pathogenic NOD2 variant in a mother and daughter with Blau syndrome. Ophthalmic Genet. 2021;42(6):753\u201364.","journal-title":"Ophthalmic Genet"},{"issue":"1","key":"743_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4049\/jimmunol.1402330","volume":"194","author":"J Dugan","year":"2015","unstructured":"Dugan J, Griffiths E, Snow P, Rosenzweig H, Lee E, Brown B, et al. Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice. J Immunol. 2015;194(1):349\u201357.","journal-title":"J Immunol"},{"issue":"8","key":"743_CR13","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/jmedgenet-2017-105216","volume":"55","author":"ME Van Gijn","year":"2018","unstructured":"Van Gijn ME, Ceccherini I, Shinar Y, Carbo EC, Slofstra M, Arostegui JI, et al. New workflow for classification of genetic variants\u2019 pathogenicity applied to hereditary recurrent fevers by the International Study Group for Systemic Autoinflammatory Diseases (INSAID). J Med Genet. 2018;55(8):530\u20137.","journal-title":"J Med Genet"},{"issue":"6","key":"743_CR14","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/humu.20720","volume":"29","author":"F Milhavet","year":"2008","unstructured":"Milhavet F, Cuisset L, Hoffman HM, Slim R, El-Shanti H, Aksentijevich I, et al. The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat. 2008;29(6):803\u20138.","journal-title":"Hum Mutat"},{"key":"743_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1546-0096-12-33","volume":"12","author":"CH Wouters","year":"2014","unstructured":"Wouters CH, Maes A, Foley KP, Bertin J, Rose CD. Blau syndrome, the prototypic auto-inflammatory granulomatous disease. Pediatr Rheumatol Online J. 2014;12:33.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"743_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12016-017-8666-8","volume":"54","author":"B Terziroli Beretta-Piccoli","year":"2018","unstructured":"Terziroli Beretta-Piccoli B, Mainetti C, Peeters MA, Laffitte E. Cutaneous granulomatosis: a comprehensive review. Clin Rev Allergy Immunol. 2018;54(1):131\u201346.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"743_CR17","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jaci.2012.02.004","volume":"129","author":"CE Janssen","year":"2012","unstructured":"Janssen CE, Rose CD, De Hertogh G, Martin TM, Bader Meunier B, Cimaz R, et al. Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2-related disorders Blau syndrome and Crohn disease. J Allergy Clin Immunol. 2012;129(4):1076\u201384.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"743_CR18","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1093\/rheumatology\/keu437","volume":"54","author":"CD Rose","year":"2015","unstructured":"Rose CD, Pans S, Casteels I, Anton J, Bader-Meunier B, Brissaud P, et al. Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes. Rheumatology (Oxford). 2015;54(6):1008\u201316.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"743_CR19","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1186\/ar4533","volume":"16","author":"K Ikeda","year":"2014","unstructured":"Ikeda K, Kambe N, Takei S, Nakano T, Inoue Y, Tomiita M, et al. Ultrasonographic assessment reveals detailed distribution of synovial inflammation in Blau syndrome. Arthritis Res Ther. 2014;16(2):R89.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"743_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12969-021-00505-5","volume":"19","author":"F Okazaki","year":"2021","unstructured":"Okazaki F, Wakiguchi H, Korenaga Y, Nakamura T, Yasudo H, Uchi S, et al. A novel mutation in early-onset sarcoidosis\/Blau syndrome: an association with Propionibacterium acnes. Pediatr Rheumatol Online J. 2021;19(1):18.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"743_CR21","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/ICU.0000000000000705","volume":"31","author":"S Suresh","year":"2020","unstructured":"Suresh S, Tsui E. Ocular manifestations of Blau syndrome. Curr Opin Ophthalmol. 2020;31(6):532\u20137.","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"743_CR22","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.immuni.2014.12.010","volume":"41","author":"R Caruso","year":"2014","unstructured":"Caruso R, Warner N, Inohara N, Nunez G. NOD1 and NOD2: signaling, host defense, and inflammatory disease. Immunity. 2014;41(6):898\u2013908.","journal-title":"Immunity"},{"issue":"3","key":"743_CR23","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1182\/blood-2004-07-2972","volume":"105","author":"N Kanazawa","year":"2005","unstructured":"Kanazawa N, Okafuji I, Kambe N, Nishikomori R, Nakata-Hizume M, Nagai S, et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood. 2005;105(3):1195\u20137.","journal-title":"Blood"},{"issue":"1","key":"743_CR24","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jaci.2017.04.013","volume":"141","author":"S Takada","year":"2018","unstructured":"Takada S, Kambe N, Kawasaki Y, Niwa A, Honda-Ozaki F, Kobayashi K, et al. Pluripotent stem cell models of Blau syndrome reveal an IFN-gamma-dependent inflammatory response in macrophages. J Allergy Clin Immunol. 2018;141(1):339-49 e11.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"743_CR25","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/art.24222","volume":"60","author":"TM Martin","year":"2009","unstructured":"Martin TM, Zhang Z, Kurz P, Rose CD, Chen H, Lu H, et al. The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity. Arthritis Rheum. 2009;60(2):611\u20138.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"743_CR26","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.1074\/jbc.M008072200","volume":"276","author":"Y Ogura","year":"2001","unstructured":"Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G. Nod2, a Nod1\/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem. 2001;276(7):4812\u20138.","journal-title":"J Biol Chem"},{"issue":"6","key":"743_CR27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/sj.icb.7100105","volume":"85","author":"M Kaparakis","year":"2007","unstructured":"Kaparakis M, Philpott DJ, Ferrero RL. Mammalian NLR proteins; discriminating foe from friend. Immunol Cell Biol. 2007;85(6):495\u2013502.","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"743_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nri1747","volume":"6","author":"W Strober","year":"2006","unstructured":"Strober W, Murray PJ, Kitani A, Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol. 2006;6(1):9\u201320.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"743_CR29","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1053\/gast.2003.50157","volume":"124","author":"P Rosenstiel","year":"2003","unstructured":"Rosenstiel P, Fantini M, Brautigam K, Kuhbacher T, Waetzig GH, Seegert D, et al. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology. 2003;124(4):1001\u20139.","journal-title":"Gastroenterology"},{"issue":"47","key":"743_CR30","doi-asserted-by":"publisher","first-page":"39800","DOI":"10.1074\/jbc.M112.410027","volume":"287","author":"KH Lee","year":"2012","unstructured":"Lee KH, Biswas A, Liu YJ, Kobayashi KS. Proteasomal degradation of Nod2 protein mediates tolerance to bacterial cell wall components. J Biol Chem. 2012;287(47):39800\u201311.","journal-title":"J Biol Chem"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00743-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-022-00743-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00743-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T12:07:15Z","timestamp":1664798835000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-022-00743-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["743"],"URL":"https:\/\/doi.org\/10.1186\/s12969-022-00743-1","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,3]]},"assertion":[{"value":"8 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was in compliance with the Declaration of Helsinki and was approved by the CGMH Institutional Review Board (IRB No.: 201802287A3).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent forms were signed by the patients\u2019 guardians \/ parents before study entrance.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}